Pace Life Sciences Names Head of Commercial

Pace Life Sciences, a full-service contract development and manufacturing organization (CDMO), has named Dean Bornilla as Head of Commercial.

Drawing on more than 25 years of pharmaceutical expertise, Bornilla will lead commercial growth teams in partnering with new and existing clients and building upon the company’s reputation for quality, agility, and accelerating the drug development process through direct collaboration with acclaimed scientists. 

“Dean’s commitment to excellence and innovation coupled with his proven track record and leadership experience will be valuable to Pace and our clients,” stated Dawn Von Rohr, President, Pace Life Sciences. “I’m confident that he will be successful in helping us to elevate our offerings in the pharmaceutical industry.” 

Prior to Pace, Bornilla was Head of North America sales for Selvita where he built a US drug discovery and development commercial platform. He also served at Curia, formerly AMRI, where his leadership skills and commercial acumen expanded the company’s drug discovery & development, API manufacturing, and Drug Product pipelines.